Insider Transactions in Q4 2023 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.53%
|
$420,000
$42.47 P/Share
|
|
Dec 26
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.84%
|
$30,000
$3.5 P/Share
|
|
Dec 26
2023
|
Kathleen Tregoning |
BUY
Exercise of conversion of derivative security
|
Direct |
3,150
+22.8%
|
$31,500
$10.05 P/Share
|
|
Dec 22
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
8,000
-24.49%
|
$328,000
$41.45 P/Share
|
|
Dec 22
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+19.67%
|
$24,000
$3.5 P/Share
|
|
Dec 20
2023
|
Mark Bodenrader |
SELL
Open market or private sale
|
Direct |
7,889
-30.8%
|
$323,449
$41.42 P/Share
|
|
Dec 20
2023
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,072
-49.42%
|
$289,952
$41.42 P/Share
|
|
Dec 20
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,256
-20.23%
|
$256,496
$41.42 P/Share
|
|
Dec 20
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,152
-40.89%
|
$416,232
$41.42 P/Share
|
|
Dec 20
2023
|
Kathleen Tregoning |
SELL
Open market or private sale
|
Direct |
6,288
-45.55%
|
$257,808
$41.42 P/Share
|
|
Dec 20
2023
|
Susan Altschuller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,808
-44.95%
|
$566,128
$41.42 P/Share
|
|
Dec 19
2023
|
Paul D. Burgess |
BUY
Exercise of conversion of derivative security
|
Direct |
23,847
+34.28%
|
-
|
|
Dec 19
2023
|
Mark Bodenrader |
BUY
Exercise of conversion of derivative security
|
Direct |
19,284
+28.73%
|
-
|
|
Dec 19
2023
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,796
+49.09%
|
-
|
|
Dec 19
2023
|
Kenneth Di Pietro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,913
+31.03%
|
-
|
|
Dec 19
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,825
+50.0%
|
-
|
|
Dec 19
2023
|
Ronald C Renaud Jr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
160,452
+50.0%
|
-
|
|
Dec 19
2023
|
Kathleen Tregoning |
BUY
Exercise of conversion of derivative security
|
Direct |
13,804
+50.0%
|
-
|
|
Dec 19
2023
|
Susan Altschuller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,721
+50.0%
|
-
|
|
Dec 15
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$307,500
$41.39 P/Share
|
|
Dec 15
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$67,500
$9.88 P/Share
|
|
Dec 07
2023
|
Ramiro Sanchez Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$410,000
$41.37 P/Share
|
|
Dec 07
2023
|
Ramiro Sanchez Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.5 P/Share
|
|
Dec 07
2023
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-95.12%
|
$410,000
$41.37 P/Share
|
|
Dec 07
2023
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+48.75%
|
$130,000
$13.17 P/Share
|
|
Dec 05
2023
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-93.6%
|
$262,500
$35.0 P/Share
|
|
Dec 05
2023
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+48.35%
|
$97,500
$13.17 P/Share
|
|
Nov 14
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
22,824
-89.41%
|
$570,600
$25.13 P/Share
|
|
Nov 14
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
22,824
+47.2%
|
$68,472
$3.5 P/Share
|
|
Nov 08
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
100
-3.57%
|
$2,500
$25.16 P/Share
|
|
Nov 08
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+3.44%
|
$300
$3.5 P/Share
|
|
Nov 07
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
27,076
-90.92%
|
$676,900
$25.02 P/Share
|
|
Nov 07
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
27,076
+47.62%
|
$81,228
$3.5 P/Share
|
|
Nov 03
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
61,401
-95.78%
|
$1,535,025
$25.43 P/Share
|
|
Nov 03
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
61,401
+48.92%
|
$184,203
$3.5 P/Share
|
|
Nov 02
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
38,599
-93.45%
|
$964,975
$25.19 P/Share
|
|
Nov 02
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
38,599
+48.31%
|
$115,797
$3.5 P/Share
|
|
Nov 01
2023
|
Deval L Patrick |
SELL
Open market or private sale
|
Direct |
30,130
-90.18%
|
$753,250
$25.0 P/Share
|
|
Nov 01
2023
|
Deval L Patrick |
BUY
Exercise of conversion of derivative security
|
Direct |
30,130
+47.42%
|
$361,560
$12.62 P/Share
|
|
Oct 16
2023
|
Bain Capital Investors LLC |
BUY
Open market or private purchase
|
Indirect |
5,480,052
+7.7%
|
$120,561,144
$22.81 P/Share
|
|
Oct 16
2023
|
Adam Koppel |
BUY
Open market or private purchase
|
Indirect |
5,480,052
+7.7%
|
$120,561,144
$22.81 P/Share
|
|
Oct 16
2023
|
Christopher R Gordon |
BUY
Open market or private purchase
|
Indirect |
5,480,052
+7.7%
|
$120,561,144
$22.81 P/Share
|
|
Oct 16
2023
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
876,808
+7.51%
|
$19,289,776
$22.81 P/Share
|